(Alliance News) - Oxford Nanopore Technologies PLC shares surged on Friday as it set out upbeat guidance for the full-year. The Oxford-based specialist in DNA and RNA sequencing technologies said 2025 ...
Simply put, Illumina tends to have better profitability ratios compared to its peers. For instance, Illumina has a 68.38% ...
Turkish immigrant Oguzhan Atay started the company in 2016 with a focus on prenatal testing. Now, he’s expanding to cancer ...
DNA isn't just a long string of genetic code, but an intricate 3D structure folded inside each cell. That means the tools ...
CHINO HILLS, CALIFORNIA / ACCESS Newswire / November 6, 2025 / SOHM, Inc. (OTCID:SHMN), a pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, a leader in ...
China is set to ease restrictions on some Illumina products, giving the sequencing giant a partial reprieve. | China is set to ease restrictions on some Illumina products, giving the sequencing giant ...
Tier 1 aberrations, which are classified as those having well-established prognostic, diagnostic, or therapeutic relevance according to guidelines set by medical societies such as WHO, NCCN and ICC, ...
Prestigious Annual Awards Program Celebrates Pioneering Breakthroughs Transforming Global Health, Research and Sustainability ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback